NovaBay Pharmaceuticals, Inc.
NBY
$0.58
-$0.02-3.33%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -77.65% | -82.99% | -51.33% | -41.63% | -10.24% |
| Total Receivables | -23.14% | -79.15% | -60.00% | -61.53% | -57.06% |
| Inventory | -86.11% | -81.42% | -82.98% | -19.13% | -13.78% |
| Prepaid Expenses | 12.80% | -24.77% | 5.04% | 23.16% | -50.60% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 52.63% | -52.53% | -29.41% | -49.06% | -37.19% |
| Total Current Assets | -72.25% | -79.91% | -63.71% | -36.87% | -22.60% |
|
|
|||||
| Total Current Assets | -72.25% | -79.91% | -63.71% | -36.87% | -22.60% |
| Net Property, Plant & Equipment | -32.04% | -31.42% | -30.81% | -29.08% | -24.65% |
| Long-term Investments | -- | -- | -- | -- | -92.31% |
| Goodwill | -- | -- | -- | -- | -92.31% |
| Total Other Intangibles | -- | -- | -- | -- | -56.05% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.20% | -4.03% | -0.21% | 1.64% | 227.45% |
| Total Assets | -69.83% | -75.48% | -63.87% | -44.91% | -42.56% |
|
|
|||||
| Total Accounts Payable | -58.18% | -16.61% | -2.70% | 4.63% | -13.67% |
| Total Accrued Expenses | -52.12% | -44.14% | -44.87% | -37.84% | 77.85% |
| Short-term Debt | -95.98% | -41.27% | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -19.59% | -19.75% | -19.53% | 9.27% | 8.99% |
| Total Finance Division Other Current Liabilities | -27.93% | -61.08% | -51.50% | -47.65% | -38.81% |
| Total Other Current Liabilities | -27.93% | -61.08% | -51.50% | -47.65% | -38.81% |
| Total Current Liabilities | -56.60% | -40.49% | -11.28% | 0.49% | 23.21% |
|
|
|||||
| Total Current Liabilities | -56.60% | -40.49% | -11.28% | 0.49% | 23.21% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -95.98% | -41.27% | -- | -- | -- |
| Capital Leases | -34.00% | -32.41% | -31.15% | -30.23% | -27.38% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -51.76% | -38.99% | -12.43% | -2.14% | -32.32% |
|
|
|||||
| Common Stock & APIC | 7.36% | 5.31% | 6.82% | 6.32% | 4.65% |
| Retained Earnings | -10.00% | -9.82% | -11.60% | -10.56% | -10.49% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -78.93% | -109.68% | -122.39% | -82.01% | -61.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -99.70% | -99.72% | -50.05% | -34.41% | 246.84% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -99.70% | -99.72% | -50.05% | -34.41% | 246.84% |
|
|
|||||
| Total Common Equity | -78.93% | -109.68% | -122.39% | -82.01% | -61.71% |
| Total Preferred Equity | -99.70% | -99.72% | -50.05% | -34.41% | 246.84% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -84.77% | -107.21% | -98.20% | -68.60% | -48.95% |
|
|
|||||
